Although there have been several adverse reactions to the prevailing usage of lithium and depression treatment, this method of dealing with the mental disorder is arguably the most efficient and well-publicized one around. Generally known as an option for its purpose in treating those dealing with bipolar disorder, lithium has also been shown itself to be effective when put to use against manias and regular forms of depression.
Over the last few years, lithium and depression has been established to quickly change antidepressant non-responders to responders in lower doses than are typically required for treatment in bipolar disorder. As such, the substance’s impact on the activity levels of the neutransmitter serotonin has always piqued the interest of researchers.
Typically, sufferers who show a response to lithium and depression treatment when it is an added to an existing antidepressant do so within a couple weeks. This, of course, serves in stark contrast to the month to month and a half that general antidepressant agents require. Similarly, recent analysis has shown that nearly fifty percent of all patients do not respond properly to the first antidepressants they try, and thus, lithium and depression treatment should in fact be explored as a possible alternative.
Part of the reason that lithium and depression treatment so rarely received attention as an effective substance in the battle versus depression is because of how readily available it already is. Unlike with other medicinal treatment options that typically require years of development and the passing of countless Food and Drug Administration (FDA) rule sets, requirements and restrictions, lithium and depression requires no such red tape to be dealt with. As such, the easiest and perhaps best method to fight against the disorder essentially fell by the wayside because of how easy it was to obtain and utilize.